AUSTER MARTIN (Chief Financial Officer) sold 67.2% of their position (97.65K shares) of VENTYX BIOSCIENCES, INC. on the open market
Open‑market sale worth $2.83M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/6/2022ACC: 0000899243-22-037793
Officer· Chief Financial Officer
Since Oct 2021
-97.65K
Net shares
Net seller
$2.83M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 147.65K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
$3.45
Trade value
$172.50K
% of position
52.5%
12/2/2022
95.30K→145.30K
Common Stock
Direct
Shares
−97.65K
Price / share
$29.01
Trade value
$2.83M
% of position
67.2%
12/2/2022
145.30K→47.65K
Total
Net shares
−47.65K
Net value
-$2.66M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2022 | M · Option Exercise | +50K | $3.45 | $172.50K | 52.5% | 95.30K | 145.30K |
| Common Stock Direct | 12/2/2022 | S · Sale | −97.65K | $29.01 | $2.83M | 67.2% | 145.30K | 47.65K |
| Total | −47.65K | -$2.66M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
3.45
Held after
331.18K
Exercisable
—
12/2/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock50K shares | 12/2/2022 | M · Option Exercise | −50K | 3.45 | — | 331.18K |